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RESUME
Des études faites  chez l’homme et  l’animal  montrent  qu’une exposition chronique au plomb durant  le 
développement provoque des altérations des fonctions cognitives. Les récepteurs au glutamate de type N-
methyl-D-aspartate (NMDA), importants dans les mécanismes synaptiques impliqués dans l’apprentissage 
et la mémoire, sont les principales cibles du plomb. Il a été montré que le D-cyclosérine, un agoniste partiel 
du site glycine associé aux récepteurs NMDA, peut améliorer les fonctions cognitives.
Nous avons étudié les effets possibles d’une exposition au plomb (acetate de plomb 0.2% dans l’eau de 
boisson)  pendant  la  gestation et  la  lactation (GL),  sur  les  performances  d’apprentissage  spatial  et  de 
mémorisation chez des rats âgés de 32 jours. Nous avons également évalué la capacité du D-cyclosérine 
(30  mg/ml),  administré  quotidiennement  24h après  le  sevrage  durant  15 jours,  à  atténuer  les  déficits 
cognitifs induits par le plomb. Nos résultats indiquent que les rats exposés au plomb pendant la gestation et 
la lactation mettent signicativement plus de temps et parcourent une plus grande distance que les animaux 
contrôle pour trouver la plateforme immergée au cours de la phase d’apprentissage de la piscine de Morris. 
Toutefois,  l’administration  de  DCS  aux  animaux  GL  améliore  significativement  leurs  performances 
d’apprentissage comparées à celles des animaux GL non traités au DCS. Aucune différence de motivation 
ou des capacités de guidage visuo-moteur ne sont présents chez les GL.
Donc, l’amélioration de la fonction des récepteurs NMDA pourrait être une stratégie efficace pour améliorer 
les déficits d’apprentissage spatial associés à la neurotoxicité au plomb.
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SUMMARY
Chronic developmental lead (Pb) exposure has long been associated with cognitive dysfunction in children 
and animals. N-methyl-D-aspartate (NMDA) receptors, important in the synaptic mechanisms involved in 
learning and memory, are key target of lead toxicity. D-cycloserine (DCS), a partial agonist of the NMDA-
associated glycine site, has been recognised as a potential cognitive enhancer.
We investigated the potential effects of Pb exposure (lead acetate 0.2% through the drinking water) during 
gestation and lactation (GL), on the spatial learning and memory capacities of PN32 rats. We also evaluate 
the ability  of  DCS (30  mg/ml),  administered  daily 24h after  weaning during  15 days,  to  attenuate  Pb 
neurotoxicity-induced cognitive deficits.
Results  indicate that rats  exposed to lead during gestation and lactation have a significantly increased 
latency to find the hidden platform and cover a significant longer distance compared to control-vehicle in the 
learning phase of  the Morris water maze. However, the administration of  DCS to GL animals improved 
significantly  their  learning  performances  compared  with  GL-vehicle.  In  contrast,  there  is  no  significant 
difference  between  all  groups  during  the  probe  test  and  the  visual  cue  test.  In  conclusion,  DCS 
enhancement  of  the  NMDA receptor  function  is  an  effective  strategy to  ameliorate  neurotoxicity  lead-
associated spatial learning deficits.
1. INTRODUCTION
Lead (Pb) is a common environmental neurotoxic agent that is a major public health problem. Lead poisoning 
affects particularly the developing central nervous system [13, 24, 51]. Exposure to low levels of lead during 
early development is sufficient to cause long lasting behavioural abnormalities and cognitive deficits in human 
and experimental animals [38, 41, 59]. Pb-toxicity induces diminished IQ scores and reduced learning and 
memory capacities in children exposed early in life [5,7]. Rodents exposed to lead are impaired in cognitive 
tasks such as the step-down avoidance test, the contextual fear conditioning, the radial maze, the Morris 
water maze (MWM) [8, 28, 29, 40].
Lead alters glutamatergic function and also interferes with cholinergic and dopaminergic neurotransmission 
[6, 11, 33, 45]. This neurotoxicant impairs neurogenesis, synaptic plasticity, long-term potentiation (LTP) and 
cognitive function in experimental animals [19, 28, 55]. Several studies have indicated impairment in the 
induction, expression and maintenance of LTP in the hippocampus of animal exposed to lead during the early 
developmental period [2, 23, 20, 48]. The detrimental effects of lead on LTP and spatial learning have been 
attributed in one hand to the effect of lead on glutamate release [34, 35] and in an other hand, to the fact that 
lead is a potent inhibitor of N-methyl-D-aspartate (NMDA) receptors [18, 26]. Further, chronic exposure to 
lead alters the expression of NMDA subunit in the rat hippocampus [25, 43, 44], decreasing particularly the 
NR2A subunit expression, thus affecting NMDA complex composition, which is important in hippocampal 
development and maturation. Pb-exposition also leads to an alteration of downstream calcium signalling. 
Recent  findings  demonstrated  that  early  lead  exposure  disrupts  expression  and  phosphorylation  of  the 
cAMP-response element binding protein (CREB), a transcription factor important in synaptic plasticity and in 
learning  and  memory  [56,  57].  Therefore,  there  is  compelling  experimental  evidence  that  chronic  lead 
exposure alters NMDA function in the rat hippocampus and this effects is associated with impairments in LTP 
and spatial learning [43, 55].
An improvement of performances in various learning tasks has been described after administration of D-
cycloserine (DCS), a compound originally used as an antibiotic agent for the treatment of tuberculosis and 
later characterised as a partial agonist at the glycine modulatory site of the glutamatergic NMDA receptor [27, 
58]. DCS is a cognitive enhancer in learning tests, such as the trace eye blink conditioning and the MWM 
task  that  are  closely  dependent  on  the  hippocampus  [36,  46,  54].  Moreover,  DCS  improves  spatial 
performances of  aged memory-deficient  rats  [3,4].  Based on the above considerations,  the aims of  the 
present work were to study the effects of a chronic lead exposure during gestation and lactation on spatial 
learning and memory abilities of Wistar rats and to evaluate the effect of DCS on their performances in the 
MWM.
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2. MATERIAL AND METHODS
2.1 Animals and treatment
Experiments were carried out on Wistar rats (obtained from Charles River) weighing 200-350 g. Animals 
were housed with free access to water and food in an animal room with 12/12h light/dark cycle, at 22 ± 2 °C. 
They were mated one week after their arrival (three females and one male per cage). On pregnancy day 0 
the dams were divided into 2 groups: one group received 0.2% lead acetate (Sigma-Aldrich Incorporated, 
France) in drinking distilled water during gestation and lactation (GL),  whereas rats of  the control  group 
received distilled water without lead acetate (C), as described previously [45]. At birth, GL pups continued to 
receive lead acetate during lactation until postnatal day (PN) 21 and rats were weaned this day. Immediately 
after  the behavioural  evaluation,  the rats  were decapitated and blood samples were taken for Pb blood 
determination. Number and suffering of animals were minimised in accordance with the guidelines of the 
European Council Directive (86/609/EEC).
2.2 Drug preparation
D-Cycloserine (DCS) was obtained from Sigma-Aldrich Incorporated (France). DCS was dissolved in distilled 
water and administered (i.p.) with a constant injection volume of 1 ml/kg. In order to maintain stability of the 
solution across days, DCS was frozen (-20 °C) in 1 ml aliquots. Each day, DCS was thawed 15 min prior to 
injection.
2.3 Experimental design: chronic administration prior to assessment
Animals were exposed to Pb during gestation and lactation (GL) and controls animals receive distilled water. 
In order to test the ability of DCS to attenuate Pb neurotoxicity induced cognitive deficits, the drug therapy 
was administered beginning 24 h after weaning. Randomly chosen animals of each group were injected (i.p.) 
with 30 mg/ml DCS (n=5; n=7, respectively) or distilled water (vehicle) (n=8; n=5, respectively). All animals 
were injected once daily on days 1-15 after  weaning.  During cognitive  assessment  (PN days 32-36)  all 
subjects were given their injection 30 min prior to begin the MWM task.
2.4 Morris Water Maze Test
The Morris  water  maze  task  was used  to  assess  cognitive  function,  in  particularly spatial  learning and 
memory abilities [39]. In PN 32 rats, the test was conducted in a round white pool 90 cm in diameter with a 50 
cm high wall. The pool was filled to a depth of 30 cm with water made opaque with white, non toxic water 
based paint. Water temperature was maintained at 21 ± 1 C° with an aquarium heater. The platform of 10 cm 
in diameter and 28 cm high (i.e., 2 cm below the water’s surface) was used as the hidden goal. The pool was 
located  in  a  room  with  numerous  extra-maze  cues  that  remained  constant  throughout  the  experiment. 
Animals were tested on days 11-15 after weaning, with four trials per day for five consecutive days. On each 
trial, the animal was placed in the pool, facing the wall, at one of the four start locations (north (N), south (S), 
east (E), and west (W)). Start location sequences were randomly assigned each day prior to the start of 
testing. Rats were allowed to swim to the submerged platform placed in the NW quadrant during 60 s. If the 
platform was not found within the allowed time, the rat was manually placed onto it. Rats were allowed to rest 
on the platform for 20 s between each trial. A session of four trials was conducted each day from 9:00 to 
11:00 A.M.. The experimenter was hidden from the view of the animals. The escape latency (time to find the 
platform) and path length (distance travelled to the hidden platform) were recorded by using a videotrack 
system (Viewpoint, France). A probe test was conducted the day following the end of the training session to 
further characterise swim task performance. In this test, the platform was removed and the rat was placed 
next to and facing the S side. Animals were allowed to swim freely for the original training session length of 
time  (60 s)  for  a  single  trial.  The  time  spent  by animals  in  the  previously  correct  quadrant  (NW)  was 
measured. Visual cue test was performed two hours after the end of the probe test in order to evaluate the 
visuo-motor abilities and the motivation of the animals. It was conducted by extending a large black flag 
above the water level from the submerged platform. The maximum time allowed was the same as the original 
training sessions. The escape latency and path length were measured during a single session of four trials.
2.5. Determination of blood lead level
Blood samples were collected immediately after decapitation of animals in tubes pre-treated with 10 µl of 
heparin.  The  lead concentration in  the blood was determined  by using atomic  absorption  spectroscopy 
(model 800, Perkin Elmer).
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2.6 Statistical analysis
Results are expressed as mean ± standard error of the mean (SEM). Lead blood levels were compared 
between GL-vehicle and C-vehicle with a t-test. MWM data were analysed by two-way analyses of variance 
(ANOVAs), with the intoxication factor (GL or controls) and the treatment factor (DCS or vehicle), or a three-
way ANOVA with day as the repeated measure.  When a significant  difference was found, the Student-




A student test reveals that lead concentration in blood of rats exposed to lead during gestation and lactation 
is significantly higher than the one of control rats [t(13)=11.78, p<0.001]. Lead concentrations in blood are 
30.13 (±23.57) µg/dl for GL (n=8) and 0.30 (±0.61) µg/dl for control (n=7) rats. A three-way ANOVA with 
repeated measures comparing MWM cognitive performances during the training phase reveals a significant 
interaction between the treatment,  intoxication and the repeated measure factors  for  latency to find the 
hidden platform, which means that animals perform differently according to their intoxication and treatment 
across days [F(3,63)=6.23, p<0.001]. An intoxication x treatment x day interaction also appears for distance 
crossed [F(3,63)=4.41, p<0.01]. A two-way ANOVA was conducted to compare the learning performances of 
rats day by day. There is no significant difference between all groups during the first and second days of 
training in terms of latency to find the hidden platform and swimming distance (p>0.05). On the third day of 
learning, assessment the ANOVA reveals a significant treatment effect for escape latency [F(1,21)=4.65, 
p<0.05] and distance crossed [F(1,21)=5.79, p<0.05]. Rats treated with DCS have significant better learning 
performances than control rats. A significant intoxication by treatment interaction is observed for the fourth 
day of training in terms of escape latency and path length ([F(1,21)=5.65, p<0.05], [F(1,21)=6.02, p<0.05] 
respectively). Post-hocs reveals that rats exposed to lead during gestation and lactation and treated with 
vehicle have a significant increased escape latency (p<0.01) and cover a significant longer distance (p<0.05) 
compared to control-vehicle. The administration of DCS to GL animals improves significantly their learning 
performances compared with GL-vehicle in terms of latency to find the hidden platform (p<0.01) and distance 
crossed (p<0.01). The performances of GL rats treated with DCS do not differ significantly from those of 
control-DCS rats (p>0.05).
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Figure 1
Escape latency (A) and distance crossed before finding the platform (B) during the training phase of the Morris water 
maze task of rats exposed to lead during gestation and lactation (GL) and control rats (C), treated with D-cycloserine 
(DCS) or vehicle. Means ± SEM. *: p<0.05, **: p<0.01: GL-vehicle vs C-vehicle ; ##: p<0.01: GL-vehicle vs GL-DCS 
(ANOVA followed by Student-Newman-Keuls post-hoc).
During the probe test, there is no significant difference between all groups for the time spent in the NW quadrant 
(p>0.05).
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Figure 2
Time spent in the training quadrant (NW) during the probe test by rats exposed to lead during gestation and lactation 
(GL) and control rats (C), treated with D-cycloserine (DCS) or vehicle. Means ± SEM. No significant difference is 
observed between the different groups.
During the visual cue test, GL groups (treated with DCS or vehicle) do not present significantly different performances 
compared with control group in terms of escape latency and distance crossed (p>0.05).
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Figure 3
Escape latency (A) and distance crossed before finding the platform (B) during the cue phase of the Morris water maze 
task of rats exposed to lead during gestation and lactation (GL) and control rats (C), treated with D-cycloserine (DCS) or 
vehicle. Means ± SEM. No significant difference is observed between the different groups.
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4. DISCUSSION
The present study shows that, on one hand, a chronic lead intoxication of Wistar rats during gestation and 
lactation  resulted  in  decreased  learning  performances  in  the  MWM.  On  the  other  hand,  the  chronic 
administration of DCS at the dose of 30 mg/kg,  on days 1-15 after weaning ameliorates significantly the 
cognitive impairments of rats exposed to lead until weaning.
Several studies have revealed that Pb exposure produces neurological damage and behavioural disruptions 
in human beings and in experimental animals [1, 10, 21, 30, 32, 60]. The lowest Pb blood level at which 
behavioural abnormalities are detectable is 15-20 µg/dl in rodents and 10-15 µg/dl in children, as estimated 
by [12]. In our study, the blood lead level of animals exposed during the gestation and lactation is superior to 
the lowest Pb blood level at which are observed modification of behaviour and is close to the one described 
previously [8]. The present findings show that a Pb exposure during the gestation and lactation period causes 
learning deficits in offspring when blood Pb concentrations are increased than at control levels, as shown by 
an increase of escape latency and distance crossed before finding the hidden platform in the MWM test. 
Altered performances in water maze task have been described in rats exposed to Pb during gestation and 
lactation [29, 31]. The period of lead exposure to observe cognitive abnormalities is important as a lead 
exposition during post-weaning period [17, 49] or during one part of the gestation period [19, 42] appears not 
to be sufficient to cause learning deficits in the MWM. We observe no difference in terms of time spent in the 
target quadrant (NW) between all groups during the probe test. This result is in good agreement with those of 
[31]. Moreover, during the visible platform phase no significant difference is observed between all groups 
which means that deficits of GL- vehicle rats during the training phase are not due to visual or motivational 
troubles.
The glutamatergic system, specifically the NMDA receptor complex, is a key target site of lead neurotoxic 
action [13]. Lead exposure induces NMDA receptor functions changes [9], induces a wide variety of changes 
of intracellular signalling [15] and synaptic plasticity in hippocampus [22, 43] that are known to interfere with 
learning and memory.
One pharmacological agent that has received attention as a promising cognitive-enhancer is the NMDA-
glycine  site  partial  agonist,  D-cycloserine.  Various  studies  indicate  that  DCS  is  an  effective  cognitive 
enhancer in multiple paradigms of cognitive impairment, including models of ageing and neurological lesions 
[4, 14, 50]. The aim of our work was to evaluate the possible effect of DCS in the case of a lead intoxication 
during development. Our results show that the learning deficits of rats exposed to lead during the gestation 
and lactation could be corrected by a chronic administration of DCS, as there is no significant difference 
between the performances of GL-DCS rats and controls rats in the learning phase of the MWM. DCS has 
already been shown to ameliorate the cognitive alterations of brain-injured rats and muscarinic antagonists 
treated  rats  in  he  MWM  [47,  52,  53].  While  the  mechanism  by  which  DCS  improve  spatial  learning 
performances in animals is unknown, it is possible that the cognitive-enhancing effect of DCS is the result of 
several  different  physiological  actions.  It  has  been  suggested  that  DCS  function  to  improve  cognitive 
performances  by  activating  the  glycine  site  and  accelerating  recovery  of  the  NMDA  receptor  from 
desensitization [16, 37].
5. CONCLUSION
In  conclusion,  the  results  from  the  present  study show that  learning  deficits  induced  by a  chronic  Pb 
intoxication  during  gestation  until  weaning  can  be  corrected  by  a  chronic  administration  of  DCS. 
Understanding the cellular action of DCS can help to find a strategy to prevent and treat the effect of Pb 
intoxication during development.
Acknowledgments 
This work was supported by a Franco-Algerian grant  program. Many thanks to Pr Jean Costentin. We 
express  our  sincere  gratitude  to  Pr  Isabelle  Leroux  for  her  advice.  We  thank  the  "Laboratoire  de 
Toxicologie, CHU de Rouen" for the blood lead concentrations measurements. 
http://ajns.paans.org 74
African Journal of Neurological Sciences 2009 - Vol. 28, No 1
REFERENCES
1. ALFANO DP, LEBOUTILLIER JC, PETIT TL. Hippocampal mossy fiber pathway development in 
normal and postnatally lead-exposed rats. Exp Neurol 1982;75:308-19.
1. ALTMANN  L,  WEINSBERG  F,  SVEINSSON  K,  LILIENTHAL  H,  WIEGAND  H,  WINNEKE  G. 
Impairment  of  long-term potentiation and learning following chronic  lead exposure.  Toxicol  Lett 
1993;66: 105-12.
2. AURA J, RIEKKINEN PJ. Pre-training blocks the improving effect of tetrahydroaminoacridine and D-
cycloserine on spatial navigation performance in aged rats. Eur J Pharmacol 2000;390:313-8.
3. BAXTER MG, LANTHORN TH, FRICK KM, GOLSKI S, WAN RQ, OLTON DS. D-cycloserine, a 
novel cognitive enhancer, improves spatial memory in aged rats. Neurobiol Aging 1994;15:207-13.
4. BELLINGER D, LEVITON A, RABINOWITZ M, ALLRED E, NEEDLEMAN H, SCHOENBAUM S. 
Weight gain and maturity in fetuses exposed to low levels of lead. Environ Res 1991;54:151-8.
5. BIELARCZYK H,  TOMSIG JL,  SUSZKIW  JB.  Perinatal  low-level  lead exposure  and the septo-
hippocampal  cholinergic  system:  selective  reduction  of  muscarinic  receptors  and 
cholineacetyltransferase in the rat septum. Brain Res 1994;643:211-7.
6. CANFIELD  RL,  KREHER  DA,  CORNWELL  C,  HENDERSON  CRJ.  Low-level  lead  exposure, 
executive functioning, and learning in early childhood. Child Neuropsychol 2003;9:35-53.
7. CHEN H, MA T, HO I. Effects of developmental lead exposure on inhibitory avoidance learning and 
glutamate receptors in rats. Environ Toxicol Pharmacol 2001;9:185-191.
8. CORY-SLECHTA  DA,  FLAUGHER  CL,  EVANS  SB,  POKORA  MJ,  GREENAMYRE  JT. 
Susceptibility  of  adult  rats  to  lead-induced  changes  in  NMDA  receptor  complex  function. 
Neurotoxicol Teratol 1997;19:517-30.
9. CORY-SLECHTA  DA,  WIDZOWSKI  DV.  Low  level  lead  exposure  increases  sensitivity  to  the 
stimulus properties of dopamine D1 and D2 agonists. Brain Res 1991;553:65-74.
10.CORY-SLECHTA DA. Relationships between lead-induced learning impairments and changes in 
dopaminergic,  cholinergic,  and  glutamatergic  neurotransmitter  system  functions.  Annu  Rev 
Pharmacol Toxicol 1995;35:391-415.
11.DAVIS JM, OTTO DA, WEIL DE, GRANT LD. The comparative developmental neurotoxicity of lead 
in humans and animals. Neurotoxicol Teratol 1990;12:215-29.
12.FINKELSTEIN Y, MARKOWITZ ME, ROSEN JF. Low-level lead-induced neurotoxicity in children: 
an update on central nervous system effects. Brain Res Rev 1998;27:168-76.
13.FLOOD JF,  MORLEY JE,  LANTHORN TH.  Effect  on memory processing by D-cycloserine,  an 
agonist of the NMDA/glycine receptor. Eur J Pharmacol 1992;221:249-54.
14.FLORA GJ, SETH PK. Alterations in some membrane properties in rat brain following exposure to 
lead. Cytobios 2000;103:103-9.
15.FOSTER AC, KEMP JA. Neurobiology. Glycine maintains excitement. Nature 1989; 338: 377-8.
16.GARCIA-ARENAS G, RAMIREZ-AMAYA V, BALDERAS I, SANDOVAL J, ESCOBAR ML, RIOS C 
ET AL.. Cognitive deficits in adult rats by lead intoxication are related with regional specific inhibition 
of cNOS. Behav Brain Res 2004;149:49-59.
17.GAVAZZO P, GAZZOLI A, MAZZOLINI M, MARCHETTI C. Lead inhibition of NMDA channels in 
native and recombinant receptors. Neuroreport 2001;12:3121-5.
18.GILBERT ME, KELLY ME, SAMSAM TE, GOODMAN JH. Chronic developmental lead exposure 
reduces neurogenesis in adult rat hippocampus but does not impair spatial learning. Toxicol Sci 
2005;86:365-74.
19.GILBERT  ME,  MACK  CM,  LASLEY SM.  Chronic  developmental  lead  exposure  increases  the 
threshold for long-term potentiation in rat dentate gyrus in vivo. Brain Res 1996;736:118-24.
20.GILBERT ME, MACK CM, LASLEY SM. The influence of developmental period of lead exposure on 
long-term potentiation in the adult rat dentate gyrus in vivo. Neurotoxicology 1999a;20:57-69.
21.GILBERT ME, MACK CM, LASLEY SM. Chronic developmental lead exposure and hippocampal 
long-term potentiation: biphasic dose-response relationship. Neurotoxicology 1999b;20:71-82.
22.GILBERT ME, MACK CM. Chronic lead exposure accelerates decay of long-term potentiation in rat 
dentate gyrus in vivo. Brain Res 1998;789:139-49.
23.GOYER RA. Lead toxicity: current concerns. Environ Health Perspect 1993;100:177-87.
24.GUILARTE TR, MCGLOTHAN JL,  NIHEI MK. Hippocampal expression of  N-methyl-D-aspartate 
receptor (NMDAR1) subunit splice variant mRNA is altered by developmental exposure to Pb(2+). 
Mol Brain Res 2000;76:299-305.
25.GUILARTE TR, MICELI RC. Age-dependent effects of lead on [3H]MK-801 binding to the NMDA 
http://ajns.paans.org 75
African Journal of Neurological Sciences 2009 - Vol. 28, No 1
receptor-gated ionophore: in vitro and in vivo studies. Neurosci Lett 1992;148:27-30.
26.HOOD WF, COMPTON RP, MONAHAN JB. D-cycloserine: a ligand for the N-methyl-D-aspartate 
coupled glycine receptor has partial agonist characteristics. Neurosci Lett 1989;98:91-5.
27.JAAKO-MOVITS  K,  ZHARKOVSKY  T,  ROMANTCHIK  O,  JURGENSON  M,  MERISALU  E, 
HEIDMETS  L  ET  AL..  Developmental  lead  exposure  impairs  contextual  fear  conditioning  and 
reduces adult hippocampal neurogenesis in the rat brain. Int J Dev Neurosci 2005;23:627-35.
28.JETT DA, KUHLMANN AC, FARMER SJ, GUILARTE TR. Age-dependent effects of developmental 
lead exposure on performance in the Morris water maze. Pharmacol Biochem Behav 1997;57:271-
9.
29.KIRALY E, JONES DG. Dendritic spine changes in rat hippocampal pyramidal cells after postnatal 
lead treatment: a golgi study. Exp Neurol 1982;77:236-9.
30.KUHLMANN AC, MCGLOTHAN JL, GUILARTE TR. Developmental lead exposure causes spatial 
learning deficits in adult rats. Neurosci Lett 1997;233:101-4.
31.LANPHEAR BP, DIETRICH K, AUINGER P, COX C. Cognitive deficits associated with blood lead 
concentrations <10 microg/dl in US children and adolescents. Public Health Rep 2000;115:521-9.
32.LASLEY SM, GILBERT ME. Glutamatergic  components underlying lead-induced impairments in 
hippocampal synaptic plasticity. Neurotoxicology 2000;21:1057-68.
33.LASLEY  SM,  GILBERT  ME.  Presynaptic  glutamatergic  function  in  dentate  gyrus  in  vivo  is 
diminished by chronic exposure to inorganic lead. Brain Res 1996;736:125-34.
34.LASLEY SM, GILBERT ME. Rat hippocampal glutamate and GABA release exhibit biphasic effects 
as a function of chronic lead exposure level. Toxicol Sci 2002;66:139-47.
35.LELONG  V,  DAUPHIN  F,  BOULOUARD  M.  RS  67333  and  D-cycloserine  accelerate  learning 
acquisition in the rat. Neuropharmacology 2001;41:517-22.
36.MAYER ML, VYKLICKY LJ, CLEMENTS J. Regulation of NMDA receptor desensitization in mouse 
hippocampal neurons by glycine. Nature 1989;338:425-7.
37.MOREIRA  EG,  VASSILIEFF  I,  VASSILIEFF  VS.  Developmental  lead  exposure:  behavioral 
alterations in the short and long term. Neurotoxicol Teratol 2001;23:489-95.
38.MORRIS R. Developments of a water-maze procedure for studying spatial learning in the rat. J 
Neurosci Methods 1984;11:47-60.
39.MUNOZ  C,  GARBE  K,  LILIENTHAL  H,  WINNEKE  G.  Neuronal  depletion  of  the  amygdala 
resembles the learning deficits induced by low level lead exposure in rats.  Neurotoxicol  Teratol 
1989;11:257-64.
40.MURPHY  KJ,  REGAN  CM.  Low-level  lead  exposure  in  the  early  postnatal  period  results  in 
persisting neuroplastic deficits associated with memory consolidation. J Neurochem 1999;72:2099-
104.
41.NEWMAN  HM,  YANG  RSH,  MAGNUSSON  KR.  Effects  of  developmental  exposure  to  lead, 
magnesium and zinc mixtures on spatial learning and expression of NMDA receptor subunit mRNA 
in fischer 344 rats. Toxicol Lett 2002;126:107-19.
42.NIHEI  MK,  DESMOND  NL,  MCGLOTHAN  JL,  KUHLMANN  AC,  GUILARTE  TR.  N-methyl-D-
aspartate  receptor  subunit  changes  are  associated  with  lead-induced  deficits  of  long-term 
potentiation and spatial learning. Neuroscience 2000;99:233-42.
43.NIHEI MK, GUILARTE TR. NMDAR-2a subunit protein expression is reduced in the hippocampus of 
rats exposed to Pb2+ during development. Mol Brain Res 1999;66:42-9.
44.NOUREDDINE  D,  MILOUD  S,  ABDELKADER  A.  Effect  of  lead  exposure  on  dopaminergic 
transmission in the rat brain. Toxicology 2005;207:363-8.
45.QUARTERMAIN D, MOWER J, RAFFERTY MF, HERTING RL, LANTHORN TH. Acute but not 
chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and 
retention. Eur J Pharmacol 1994;257:7-12.
46.RIEKKINEN PJ, IKONEN S, RIEKKINEN M. Tetrahydroaminoacridine, a cholinesterase inhibitor, 
and D-cycloserine, a partial NMDA receptor-associated glycine site agonist, enhances acquisition of 
spatial navigation. Neuroreport 1998;9:1633-7.
47.RUAN DY, CHEN JT, ZHAO C, XU YZ, WANG M, ZHAO WF. Impairment of long-term potentiation 
and  paired-pulse  facilitation  in  rat  hippocampal  dentate  gyrus  following  developmental  lead 
exposure in vivo. Brain Res 1998;806:196-201.
48.SCHNEIDER JS, LEE MH, ANDERSON DW, ZUCK L, LIDSKY TI. Enriched environment during 
development is protective against lead-induced neurotoxicity. Brain Res 2001;896:48-55.
49.SCHUSTER  GM,  SCHMIDT  WJ.  D-cycloserine  reverses  the  working  memory  impairment  of 
hippocampal-lesioned rats in a spatial learning task. Eur J Pharmacol 1992;224:97-8.
50.SILBERGELD EK. Mechanisms of lead neurotoxicity, or looking beyond the lamppost.  FASEB J 
1992;6:3201-6.
http://ajns.paans.org 76
African Journal of Neurological Sciences 2009 - Vol. 28, No 1
51.SIRVIÖ  J,  EKONSALO  T,  RIEKKINEN  PJ,  LAHTINEN  H,  RIEKKINEN  PS.  D-cycloserine,  a 
modulator  of  the  N-methyl-D-aspartate  receptor,  improves  spatial  learning  in  rats  treated  with 
muscarinic antagonist. Neurosci Lett 1992;146:215-8.
52.TEMPLE MD, HAMM RJ. Chronic,  post-injury administration of  D-cycloserine,  an NMDA partial 
agonist,  enhances  cognitive  performance  following  experimental  brain  injury.  Brain  Res 
1996;741:246-51.
53.THOMPSON LT, MOSKAL JR, DISTERHOFT JF. Hippocampus-dependent learning facilitated by a 
monoclonal antibody or D-cycloserine. Nature 1992;359:638-41.
54.TOSCANO CD, GUILARTE TR. Lead neurotoxicity: from exposure to molecular effects. Brain Res 
Rev 2005;49:529-54.
55.TOSCANO CD, HASHEMZADEH-GARGARI H, MCGLOTHAN JL, GUILARTE TR. Developmental 
Pb2+ exposure alters NMDAR subtypes and reduces CREB phosphorylation in the rat brain. Dev 
Brain Res 2002;139:217-26.
56.TOSCANO CD,  MCGLOTHAN JL,  GUILARTE TR.  Lead exposure  alters  cyclic-AMP response 
element binding protein phosphorylation and binding activity in the developing rat brain. Dev Brain 
Res 2003;145:219-28.
57.WATSON  GB,  BOLANOWSKI  MA,  BAGANOFF  MP,  DEPPELER  CL,  LANTHORN  TH.  D-
cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed 
in Xenopus oocytes. Brain Res 1990;510:158-60.
58.WHITE RF, DIAMOND R, PROCTOR S, MOREY C, HU H. Residual cognitive deficits 50 years 
after lead poisoning during childhood. Br J Ind Med 1993;50:613-22.
59.YANG Y, MA Y, NI L, ZHAO S, LI L, ZHANG J ET AL. . Lead exposure through gestation-only 
caused long-term learning/memory deficits in young adult offspring. Exp Neurol 2003;184:489-95.
http://ajns.paans.org 77
